Global Hypoglossal Nerve Stimulation Therapy Market Report and Forecast 2024-2032

Global Hypoglossal Nerve Stimulation Therapy Market Outlook

The global market for hypoglossal nerve stimulation therapy is expected to grow at a CAGR of about 13.2% in the forecast period of 2024-2032, owing to the rise in the prevalence of sleep disorders.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be a Significant Regional Market for Hypoglossal Nerve Stimulation Therapy

North America is expected to dominate the hypoglossal nerve stimulation therapy market in the forecast period. Major factors such as changes in lifestyle, rise in obstructive sleep apnea (OSA), high OSA-associated disease burden, favourable reimbursement policies, strong clinical pipeline, rising stress level, growing investments in the healthcare industry, and quick adoption of technology are expected to propel the market growth. Sleep disorders, especially sleep apnea, have emerged as a major public health concern in the United States. An estimated 22 million Americans suffer from sleep apnea, with 80 percent of moderate and severe obstructive sleep apnea cases going untreated . The low awareness regarding obstructive sleep apnea (OSA) and underdiagnosed cases represent a significant market development opportunity for the key players in the region.

Moreover, due to the high prevalence of sleep disorders in the United States, the government and non-government organisations are conducting campaigns to raise general awareness among people suffering from these disorders. This is likely to support the hypoglossal nerve stimulation therapy market in the country.

Market Segmentations

The hypoglossal nerve stimulator is a medical device that is implanted and electrically stimulates the hypoglossal nerve, causing tongue movement. This stimulation is timed to coincide with breathing in order to reduce upper airway blockage. The hypoglossal nerve stimulation system is totally implanted beneath the skin and is operated by a remote, allowing patients to sleep without thinking about devices on their face or in their mouth. Hypoglossal nerve stimulation (HGNS) is a novel technique for treating moderate to severe OSA in patients who cannot tolerate CPAP therapy.

The various treatment devices in the market are:

• Aura 6000 Sleep Therapy System
• Inspire II Upper Airway Stimulation Device
• Others

Based on product type, the market is divided into:

• Battery Free
• Leadless
• Implantable
• Electrodes
• Others

The several distribution channels of the market are:

• Hypermarkets and Supermarkets
• Pharmacies and Drug Stores
• Online
• Others

The regional markets for hypoglossal nerve stimulation therapy can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Obstructive Sleep Apnea Propelling the Market Growth

The growing incidence of sleep deprivation disorders such as obstructive sleep apnea (OSA), a serious sleep disorder that increases the risk of fatal accidents or other health-related consequences caused by disrupted sleep, necessitates the global hypoglossal nerve stimulation therapy market. Hypoglossal neurostimulation devices are a relatively new, minimally sophisticated option and an innovative technique for treating obstructive sleep apnea. These devices aid in restoring the tone of the upper airway dilator muscle, hence reducing airway blockage. These devices are anticipated to provide lucrative opportunities to the market over the forecast period.

Further, the increase in chronic diseases, rise in geriatric population, growing research and development activities, along with technological advancements such as miniaturisation and automation, among others, are positively influencing the growth of the market during the forecast period. Favourable reimbursement scenarios related to implantation procedures in these facilities will further drive the market growth globally. Rising focus on operational efficiency, short stay, and highly efficient healthcare professionals will foster the market revenue. Other factors expected to fuel the market expansion during the forecast period include increasing healthcare expenditure, increasing awareness of the disorder and accessible treatment choices, which will lead to early diagnosis.

Key Players in the Global Market for Hypoglossal Nerve Stimulation Therapy

The report gives a detailed analysis of the following key players in the global hypoglossal nerve stimulation therapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Nyxoah SA.
• Fisher & Paykel Healthcare Limited
• Invacare Corporation
• Braebon Medical Corporation
• Oventus Medical USA, Inc.
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report